Supernus Pharmaceuticals Inc

Supernus CFO’s recent share buy after RSU sale shows insider confidence in CNS drug pipeline, signaling potential upside for investors amid FDA fast‑track approvals.

Supernus CFO’s insider trades signal cautious optimism—purchasing shares while selling RSUs—hinting at future pipeline gains and potential valuation lift.

Insider buying at Supernus shows confidence: Charles Nehall buys 4,475 shares and sells RSUs, hinting at a short‑term rally amid growing optimism.